Evidence map›Paper›PMID 33322454›Full record

ArticleCancers2020

The Suitability of Glioblastoma Cell Lines as Models for Primary Glioblastoma Cell Metabolism.

Anya L Arthurs, Damien J Keating, Brett W Stringer, Simon J Conn

Abstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. SP and KLF Transcription Factors in Cancer Metabolism.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Glioblastomas.Cancers · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anya L ArthursFlinders Health and Medical Research Institute, Flinders University, Adelaide, SA 5042, Australia.ORCID 0000-0002-4382-0610
Damien J KeatingFlinders Health and Medical Research Institute, Flinders University, Adelaide, SA 5042, Australia.
Brett W StringerFlinders Health and Medical Research Institute, Flinders University, Adelaide, SA 5042, Australia.ORCID 0000-0003-4552-9736
Simon J ConnFlinders Health and Medical Research Institute, Flinders University, Adelaide, SA 5042, Australia.ORCID 0000-0002-1376-4515

Funding

National Health and Medical Research Council GNT1144250
6 · The paper itself

Abstract

In contrast to most non-malignant tissue, cells comprising the brain tumour glioblastoma (GBM) preferentially utilise glycolysis for metabolism via "the Warburg effect". Research into therapeutics targeting the disease's highly glycolytic state offer a promising avenue to improve patient survival. These studies often employ GBM cell lines for in vitro studies which translate poorly to the in vivo patient context. The metabolic traits of five of the most used GBM cell lines were assessed and compared to primary GBM and matched, healthy brain tissue. In patient-derived GBM cell lines, the basal mitochondrial rate (

Indexed as

cell cultureglioblastomaglycolysismetabolic fluxmetabolismoncology

Identifiers

PMID33322454
PMCPMC7764800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.